Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company’s lead product candidate is molgramostim. An inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.
Read MoreCabaletta Bio, Inc. (CABA) Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Immix Biopharma, Inc. (IMMX) Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. […]
Read MoreProtagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of erythrocytosis, iron overload, and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block […]
Read MoreOlema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal […]
Read MoreNeoGenomics, Inc. (NEO) NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. XOMA Corporation (XOMA) XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies […]
Read MoreImmix Biopharma, Inc. (IMMX) Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. Tango Therapeutics, Inc. (TNGX) Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Wave Life Sciences Ltd. (WVE) Wave Life Sciences Ltd., a […]
Read MoreOlema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal […]
Read MoreProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system PLX $1.9200 0.0300 % 1.5900 Protalix Biotherapeutics Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 1.59% Wk: […]
Read MoreMorphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. MORF $59.2200 1.6300 % 2.8300 Morphic Holding Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: […]
Read MoreAxsome Therapeutics, Inc. (AXSM) Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Exact Sciences Corporation (EXAS) Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Olema Pharmaceuticals, Inc. (OLMA) Olema Pharmaceuticals, Inc., a […]
Read MorePowell Industries, Inc. (POWL) Powell Industries, Inc., together with its subsidiaries, designs, develops, manufactures, sells, and services custom-engineered equipment and systems for the distribution, control, and monitoring of electrical energy. Wave Life Sciences Ltd. (WVE) Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery […]
Read MoreA clinical-stage company, engages in the development of transformational treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. AKRO $53.7000 -1.5100 % -2.7400 Akero Therapeutics Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: -2.74% Wk: […]
Read More89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. ETNB $20.8600 -0.5300 % -2.4800 89Bio Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: -2.48% Wk: 6.1% Mo: 21.05% Yrly: 579.05% […]
Read More89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. ETNB $18.0700 0.7900 % 4.5700 89Bio Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 4.57% Wk: -0.23% Mo: 3.91% Yrly: 517.14% […]
Read MoreBuy Price: $15.30 or better Sell Price: TradersPro Sell Signal Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. The stocks found in the One Hot Stock category use stocks that are in long term, short term trends and are early in the buy signal […]
Read More